Status and phase
Conditions
Treatments
About
To compare the incidence of acute kidney injury (AKI) post percutaneous coronary intervention (PCI) in a Dapagliflozin treated group versus a group managed with the usual standard of care.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
250 participants in 2 patient groups
Loading...
Central trial contact
Gregg S Pressman, MD; Francisco A Aguilar, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal